| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Cobb Stuart is a Chief Scientific Officer at NGNE. Recent filings cover 0 purchases and 3 sales. Those positions are worth an estimated $680K at current prices.
Cobb Stuart's largest disclosed position is in NGNE as Chief Scientific Officer, worth about $680K. The recent filings there lean toward selling, a net 6,797 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | NGNE Neurogene Inc. | Chief Scientific Officer | Sell | 6,797 | $20.81 | $141,445.87 | -18.2% |